The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies Lawrence TollAndrea CippitelliAkihiko Ozawa Leading Article 31 May 2021 Pages: 591 - 607
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability Roberta RobertiCarmen De CaroEmilio Russo Review Article 16 May 2021 Pages: 609 - 618
Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention Erica BellPhil BoyceGin S. Malhi Review Article 21 May 2021 Pages: 619 - 641
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status Robert L. FindlingShawn A. CandlerJeffrey H. Newcorn Review Article Open access 18 May 2021 Pages: 643 - 653
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study Federico BertoliniGiovanni OstuzziThe STAR Network Investigators Original Research Article Open access 29 March 2021 Pages: 655 - 665
Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension Margaret Danielle WeissCraig SurmanGraeme Donnelly Original Research Article Open access 31 May 2021 Pages: 667 - 679
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage Juan SongYong WangChanglian Zhu Original Research Article Open access 06 May 2021 Pages: 681 - 690
Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use Julia Paik Adis Drug Q&A 31 May 2021 Pages: 691 - 700
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use James E. Frampton Correction 21 May 2021 Pages: 701 - 701